SLNG Earnings

SLNG reported its FY2025Q3 earnings on 2025-11-05, showcasing a revenue of 20.32M against an estimate of 17.30M, resulting in a 17.49% surprise. The EPS was 0.06, surpassing the expected 0 by 0%. The stock experienced a -3.99% price change on the earnings day and a -2.33% change over the next five days, reflecting market reactions to the results.

Following SLNG's FY2025Q3 earnings announcement on 2025-11-05, the stock price moved by -3.99% on the day of the release. Over the subsequent five days, it saw a -2.33% change. Historically, SLNG's stock price tends to shift by an average of -0.8% in the 10 days leading up to earnings and -9.88% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate SLNG's annual revenue to reach 21.90M, while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SLNG's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SLNG's stock price typically moves by -0.8% in the 10 days before its earnings and -9.88% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of and revenue of 21.90M.

The earnings call suggests a positive outlook with strong revenue growth in aerospace and marine sectors, strategic reinvestment in the U.S., and effective cost management. Despite some uncertainties, the company is optimistic about future growth, especially in Canada. The Q&A revealed no major concerns and highlighted strong performance in contact lenses and a bullish outlook for Q4. Overall, the positive aspects outweigh the negatives, indicating a likely stock price increase over the next two weeks.